SEL1L regulates adhesion, proliferation and secretion of insulin by affecting integrin signaling

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Diaferia, Giuseppe R ^a,e   Cirulli, Vincenzo ^b   Biunno, Ida ^c,d  

^a Integrated Systems Engineering   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c IRCCS MULTIMEDICA   (Italy)

^d Milan Unit   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, CD29; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INSULIN; MICE; PANCREAS; PROTEIN BINDING; PROTEINS; SIGNAL TRANSDUCTION;

EID: 84894274987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079458     Document Type: Article

References (62)

1. Biunno I, Cattaneo M, Orlandi R, Canton C, Biagiotti L, et al. (2006) SEL1L a multifaceted protein playing a role in tumor progression. J Cell Physiol 208: 23-38. (Pubitemid 43848986)
2. Mueller B, Klemm EJ, Spooner E, Claessen JH, Ploegh HL (2008) SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins. Proc Natl Acad Sci U S A 105: 12325-12330.
3. Tyler RE, Pearce MM, Shaler TA, Olzmann JA, Greenblatt EJ, et al. (2012) Unassembled CD147 is an endogenous endoplasmic reticulum-associated degradation substrate. Mol Biol Cell 23: 4668-4678.
4. Zhou P, Hoffman J, Landau H, Hassoun H, Iyer L, et al. (2012) Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis. Clin Lymphoma Myeloma Leuk 12: 49-58.
5. Bernasconi R, Galli C, Calanca V, Nakajima T, Molinari M (2010) Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates. J Cell Biol 188: 223-235.
6. Bernasconi R, Galli C, Noack J, Bianchi S, de Haan CA, et al. (2012) Role of the SEL1L:LC3-I complex as an ERAD tuning receptor in the mammalian ER. Mol Cell 46: 809-819.
7. Cattaneo M, Dominici R, Cardano M, Diaferia G, Rovida E, et al. (2012) Molecular chaperones as therapeutic targets to counteract proteostasis defects. J Cell Physiol 227: 1226-1234.
8. Cattaneo M, Otsu M, Fagioli C, Martino S, Lotti LV, et al. (2008) SEL1L and HRD1 are involved in the degradation of unassembled secretory Ig-mu chains. J Cell Physiol 215: 794-802. (Pubitemid 351632701)
9. Biunno I, Appierto V, Cattaneo M, Leone BE, Balzano G, et al. (1997) Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. Genomics 46: 284-286. (Pubitemid 28013425)
10. Donoviel DB, Bernstein A (1999) SEL-1L maps to human chromosome 14, near the insulin-dependent diabetes mellitus locus 11. Genomics 56: 232-233. (Pubitemid 29141157)
11. Field LL, Tobias R, Thomson G, Plon S (1996) Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 33: 1-8. (Pubitemid 26119389)
12. Larsen ZM, Angelo AD, Cattaneo M, Nerup J, Biunno I, et al. (2001) Complete mutation scanning of the human SEL 1L gene: a candidate gene for type 1 diabetes. Acta Diabetol 38: 191-192. (Pubitemid 34145699)
13. Pociot F, Larsen ZM, Zavattari P, Deidda E, Nerup J, et al. (2001) No evidence for SEL1L as a candidate gene for IDDM11-conferred susceptibility. Diabetes Metab Res Rev 17: 292-295. (Pubitemid 32821661)
14. Kim SH, Ma X, Klupa T, Powers C, Pezzolesi M, et al. (2003) Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24. Diabetes 52: 2182-2186. (Pubitemid 36919815)
15. Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345: 971-980.
16. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, et al. (2001) beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 Suppl 1: S94-100.
17. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, et al. (1993) Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328: 697-702. (Pubitemid 23073372)
18. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, et al. (1999) Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23: 323-328. (Pubitemid 29526431)
19. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, et al. (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303: 1378-1381. (Pubitemid 38269432)
20. Francisco AB, Singh R, Li S, Vani AK, Yang L, et al. (2010) Deficiency of suppressor enhancer Lin12 1 like (SEL1L) in mice leads to systemic endoplasmic reticulum stress and embryonic lethality. J Biol Chem 285: 13694-13703.
21. Yagishita N, Ohneda K, Amano T, Yamasaki S, Sugiura A, et al. (2005) Essential role of synoviolin in embryogenesis. J Biol Chem 280: 7909-7916. (Pubitemid 40349688)
22. Francisco AB, Singh R, Sha H, Yan X, Qi L, et al. (2011) Haploid insufficiency of suppressor enhancer Lin12 1-like (SEL1L) protein predisposes mice to high fat diet-induced hyperglycemia. J Biol Chem 286: 22275-22282.
23. Li S, Francisco AB, Munroe RJ, Schimenti JC, Long Q (2010) SEL1L deficiency impairs growth and differentiation of pancreatic epithelial cells. BMC Dev Biol 10: 19.
24. Diaferia G, Cattaneo M, Saltini G, Proverbio MC, Monferini E, et al. (2004) RNA-mediated interference indicates that SEL1L plays a role in pancreatic beta-cell growth. DNA Cell Biol 23: 510-518. (Pubitemid 39050557)
25. Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1: S119-124. (Pubitemid 38168703)
26. Park KG, Lee KM, Seo HY, Suh JH, Kim HS, et al. (2007) Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partner. Diabetes 56: 431-437.
27. Seo HY, Kim YD, Lee KM, Min AK, Kim MK, et al. (2008) Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insulin gene expression via up-regulation of orphan nuclear receptor small heterodimer partner. Endocrinology 149: 3832-3841.
28. Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150: 1223-1234.
29. Liu Q, Chen J, Mai B, Amos C, Killary AM, et al. (2012) A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Mol Carcinog 51: 433-438.
30. Saltini G, Proverbio MC, Malferrari G, Biagiotti L, Boettcher P, et al. (2004) Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy. Mutat Res 554: 159-163. (Pubitemid 39140824)
31. Kyostila K, Cizinauskas S, Seppala EH, Suhonen E, Jeserevics J, et al. (2012) A SEL1L mutation links a canine progressive early-onset cerebellar ataxia to the endoplasmic reticulum-associated protein degradation (ERAD) machinery. PLoS Genet 8: e1002759.
32. Biunno I, Castiglioni B, Rogozin IB, DeBellis G, Malferrari G, et al. (2002) Cross-species conservation of SEL1L, a human pancreas-specific expressing gene. Omics 6: 187-198. (Pubitemid 35282442)
33. Chothia C, Jones EY (1997) The molecular structure of cell adhesion molecules. Annu Rev Biochem 66: 823-862. (Pubitemid 27274676)
34. Steffensen B, Bigg HF, Overall CM (1998) The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. J Biol Chem 273: 20622-20628. (Pubitemid 28377633)
35. Kaido TJ, Yebra M, Kaneto H, Cirulli V, Hayek A, et al. (2010) Impact of integrin-matrix interaction and signaling on insulin gene expression and the mesenchymal transition of human beta-cells. J Cell Physiol 224: 101-111.
36. Kaido T, Yebra M, Cirulli V, Montgomery AM (2004) Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. J Biol Chem 279: 53762-53769. (Pubitemid 40051885)
37. Kaido T, Yebra M, Cirulli V, Rhodes C, Diaferia G, et al. (2006) Impact of defined matrix interactions on insulin production by cultured human beta-cells: effect on insulin content, secretion, and gene transcription. Diabetes 55: 2723-2729. (Pubitemid 44923670)
38. Diaferia GR, Jimenez-Caliani AJ, Ranjitkar P, Yang W, Hardiman G, et al. (2013) Beta1-integrin is a critical regulator of pancreatic beta-cell expansion. Development 140: 3360-3372.
39. Altirriba J, Barbera A, Del Zotto H, Nadal B, Piquer S, et al. (2009) Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. BMC Genomics 10: 406.
40. Calabrese A, Zhang M, Serre-Beinier V, Caton D, Mas C, et al. (2003) Connexin 36 controls synchronization of Ca2+ oscillations and insulin secretion in MIN6 cells. Diabetes 52: 417-424. (Pubitemid 36173198)
41. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, et al. (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132. (Pubitemid 20228111)
42. Sutton R, Peters M, McShane P, Gray DW, Morris PJ (1986) Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42: 689-691. (Pubitemid 17210307)
43. Bosco D, Meda P, Halban PA, Rouiller DG (2000) Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes 49: 233-243. (Pubitemid 30071002)
44. Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, et al. (1995) Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes 44: 1458-1460.
45. Beattie GM, Lappi DA, Baird A, Hayek A (1991) Functional impact of attachment and purification in the short term culture of human pancreatic islets. J Clin Endocrinol Metab 73: 93-98. (Pubitemid 21901105)
46. Cirulli V, Beattie GM, Klier G, Ellisman M, Ricordi C, et al. (2000) Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. J Cell Biol 150: 1445-1460.
47. Orlandi R, Cattaneo M, Troglio F, Campiglio M, Biunno I, et al. (2002) Production of a monoclonal antibody directed against the recombinant SEL1L protein. Int J Biol Markers 17: 104-111. (Pubitemid 34873795)
48. Yebra M, Diaferia GR, Montgomery AM, Kaido T, Brunken WJ, et al. (2011) Endothelium-derived Netrin-4 supports pancreatic epithelial cell adhesion and differentiation through integrins alpha2beta1 and alpha3beta1. PLoS One 6: e22750.
49. Lilley BN, Ploegh HL (2005) Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 102: 14296-14301. (Pubitemid 41429692)
50. Yu CR, Mahdi RM, Ebong S, Vistica BP, Chen J, et al. (2004) Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J Immunol 173: 737-746. (Pubitemid 38924247)
51. Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA, Wallace RW, et al. (1990) A cystic fibrosis pancreatic adenocarcinoma cell line. Proc Natl Acad Sci U S A 87: 4012-4016.
52. Yebra M, Montgomery AM, Diaferia GR, Kaido T, Silletti S, et al. (2003) Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration. Dev Cell 5: 695-707. (Pubitemid 37362214)
53. Cattaneo M, Fontanella E, Canton C, Delia D, Biunno I (2005) SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions. Neoplasia 7: 1030-1038.
54. Cattaneo M, Canton C, Albertini A, Biunno I (2004) Identification of a region within SEL1L protein required for tumour growth inhibition. Gene 326: 149-156. (Pubitemid 38068496)
55. Kaneko M, Yasui S, Niinuma Y, Arai K, Omura T, et al. (2007) A different pathway in the endoplasmic reticulum stress-induced expression of human HRD1 and SEL1 genes. FEBS Lett 581: 5355-5360. (Pubitemid 350101515)
56. Yamada KM, Kennedy DW (1987) Peptide inhibitors of fibronectin, laminin, and other adhesion molecules: unique and shared features. J Cell Physiol 130: 21-28. (Pubitemid 17011043)
57. Ruoslahti E (1996) RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715.
58. Koivunen E, Gay DA, Ruoslahti E (1993) Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J Biol Chem 268: 20205-20210. (Pubitemid 23278923)
59. Humphries MJ (1996) Integrin activation: the link between ligand binding and signal transduction. Curr Opin Cell Biol 8: 632-640.
60. Rusnati M, Tanghetti E, Dell'Era P, Gualandris A, Presta M (1997) alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol Biol Cell 8: 2449-2461. (Pubitemid 27528213)
61. Chuman Y, Uren A, Cahill J, Regan C, Wolf V, et al. (2004) Identification of a peptide binding motif for secreted frizzled-related protein-1. Peptides 25: 1831-1838. (Pubitemid 39389176)
62. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, et al. (2005) Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123: 1307-1321. (Pubitemid 41821787)